View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
September 21, 2010

Corindus Coronary Intervention System Performs Well in Trials

Corindus Vascular Robotics has revealed positive study results for their CorPath 200 System, which is used to deliver and manipulate coronary guidewires and stent / balloon systems in percutaneous coronary intervention procedures. The first-in-human trial evaluated the safety and technic

By cms admin

Corindus Vascular Robotics has revealed positive study results for their CorPath 200 System, which is used to deliver and manipulate coronary guidewires and stent / balloon systems in percutaneous coronary intervention procedures.

The first-in-human trial evaluated the safety and technical efficacy of the CorPath 200 System in eight patients.

The study achieved its primary endpoint of zero major adverse cardiac event at 48 hours, and the procedure time was similar to that of a conventional manual procedure.

All patients in the study were discharged with less than 30% stenosis and a 30-day follow-up showed no major adverse cardiac events.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management